Cargando…
Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
BACKGROUND & OBJECTIVES: The global pandemic caused by SARS-CoV-2 virus has challenged public health system worldwide due to the unavailability of approved preventive and therapeutic options. Identification of neutralizing antibodies (NAb) and understanding their role is important. However, the...
Autores principales: | Deshpande, Gururaj Rao, Sapkal, Gajanan N., Tilekar, Bipin N., Yadav, Pragya D., Gurav, Yogesh, Gaikwad, Shivshankar, Kaushal, Himanshu, Deshpande, Ketki S., Kaduskar, Ojas, Sarkale, Prasad, Baradkar, Srikant, Suryawanshi, Annasaheb, Lakra, Rajen, Sugunan, A.P., Balakrishnan, Anukumar, Abraham, Priya, Salve, Pavan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853248/ https://www.ncbi.nlm.nih.gov/pubmed/32859866 http://dx.doi.org/10.4103/ijmr.IJMR_2382_20 |
Ejemplares similares
-
Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
por: Sapkal, Gajanan, et al.
Publicado: (2020) -
Understanding the dynamics of IgM & IgG antibodies in COVID-19-positive patients
por: Kaduskar, Ojas, et al.
Publicado: (2022) -
Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection
por: Mohandas, Sreelekshmy, et al.
Publicado: (2020) -
Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2
por: Deshpande, Gururaj Rao, et al.
Publicado: (2021) -
Molecular characterization of chikungunya virus from urbanized villages of Pune, Maharashtra, India, 2016
por: Deshpande, Gururaj Rao, et al.
Publicado: (2018)